Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Clinical trial NCT07307053 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07307053
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rare Malignant Neoplasm Advanced Solid Tumors Metastatic Solid Tumors

Start date: 2026-01-01
Primary completion: 2029-01-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.